Arvinas, Inc. (ARVN) vs CytomX Therapeutics, Inc. (CTMX)

• Arvinas, Inc. ARVN 7.56 ▼ −3.82%
• CytomX Therapeutics, Inc. CTMX 2.24 ▼ −4.27%

Arvinas, Inc. and CytomX Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and CytomX Therapeutics, Inc. are of similar size ($513.9M and $509.9M). CytomX Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 41.0×. Arvinas, Inc. grew revenue faster over the last twelve months: −15.1% against −87.0%. Arvinas, Inc. has the higher net margin (2.94% vs −451.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arvinas, Inc. leads on 13 and CytomX Therapeutics, Inc. on 4.